Claritev
CTEV

Claritev (CTEV) analyst forecast and price target

Analyst forecast

Buy

Consensus of 5 analyst ratings

Buy
4
Hold
1
Sell
0
Average price target
$39.50+65.55% vs. last price
Last $23.86
Low $30.00High $45.00

Based on 4 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysMaintainedOverweight$40.00 from $28.00Aug 21, 2026
Wells FargoMaintainedEqual-Weight$30.00 from $22.00Aug 12, 2026
Canaccord GenuityMaintainedBuy$43.00 from $37.00Aug 10, 2026
CitigroupMaintainedBuy$45.00 from $40.00Aug 10, 2026
Canaccord GenuityMaintainedBuy$37.00 from $32.00Jul 21, 2026
Canaccord GenuityInitiated CoverageBuy$32.00May 29, 2026
BarclaysInitiated CoverageOverweight$28.00Apr 24, 2026
Wells FargoMaintainedEqual-Weight$22.00 from $30.00Mar 19, 2026
CitigroupMaintainedBuy$21.00 from $63.00Feb 25, 2026
GuggenheimMaintainedBuy$38.00 from $43.00Feb 24, 2026
Wells FargoMaintainedEqual-Weight$30.00 from $33.00Feb 24, 2026
CitigroupMaintainedBuy$63.00 from $80.00Jan 9, 2026
Wells FargoInitiated CoverageEqual-Weight$33.00Jan 9, 2026
CitigroupMaintainedBuy$80.00 from $74.00Nov 10, 2025
CitigroupUpgradedNeutral → Buy$74.00 from $55.00Oct 22, 2025
CitigroupUpgradedNeutral → Buy$55.00Oct 21, 2025
Piper SandlerMaintainedOverweight$86.00 from $44.00Aug 15, 2025
Piper SandlerUpgradedNeutral → Overweight$44.00 from $19.00May 29, 2025
Piper SandlerMaintainedNeutral$19.00 from $10.00Mar 10, 2025
CitigroupMaintainedNeutral$12.50 from $10.00Jan 10, 2025

Frequently asked questions

  • What is the price target for CTEV stock?

    The average 12-month analyst price target for Claritev (CTEV) is $39.50, with a high estimate of $45.00 and a low of $30.00, across 4 analysts.

  • Is CTEV a buy, sell, or hold?

    Analysts covering Claritev currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for CTEV?

    The average price target of $39.50 implies 65.55% upside from the last price of $23.86.

  • What is the latest analyst rating on CTEV?

    On Aug 21, 2026, Barclays maintained Claritev at Overweight with a price target of $40.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.